Top Industry Stories – July 28, 2009 « Medical Dynamics

THE LATEST WORD

Top Industry Stories – July 28, 2009

Posted on July 28th, 2009 | by Rxmedyn | No Comments »

“Wockhardt Signs Pact To Sell Its Nutrition Ops To Abbott” (Wall Street Journal)
“Supernus Pharmaceuticals Closes Second Non-Dilutive Financing” (Press release issued by Supernus Pharmaceuticals, Business Wire)
“FDA Giving King’s CorVue A Chance Despite Failed Trials” (The Pink Sheet)
“Global General Technologies, Inc (GLGT) Announces Acquisition of I.T.I. Bio-Tech” (Press release issued by Global General Technologies, PRNewswire)
“Bristol-Myers starts $16 tender offer for Medarex” (The Associated Press)
“Israel stocks steady; Teva beats the estimates” (MarketWatch)
“FDA: Schering psychiatric appears safe, effective” (The Associated Press)
“Mylan says FDA finds plant issues were minor, shares rise” (Reuters)
“Ariad posts positive early breast cancer test data” (CNBC)
“Medicis rises on approval of new acne drug doses” (CNBC)
“Teva 2Q Pft Slips 2.3% On Charges; Earnings Beat Views” (Wall Street Journal)
“Amgen Announces Deal With Glaxo” (Reuters, The New York Times)
“Bristol-Myers Squibb Begins Tender Offer to Acquire Medarex, Inc.” (Press release issued by Bristol-Myers Squibb, Business Wire)
“Fort Myers-based cancer genetics testing company’s profits slightly drop” (News-Press)
“Amgen 2Q profit rises 40 percent on lower costs” (The Associated Press)
“MonArc Corporation (MONA:PK) Finalizes Sale ITI Biotech Subsidiary (GLGT)” (Press release issued by MonArc Corporation, PRNewswire)
“QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System” (Press release issued by MonArc Corporation, PRNewswire)
“Lilly, BioMS scrap MS drug after trial fails” (Reuters)
“FDA delays Intuniv but Shire still sees Q4 launch” (Reuters)
“FDA Heat Fails to Scorch Appeal of Indian Pharma” (Wall Street Journal)
“What You Should Know About Generic Drugs” (Forbes)
“Sanofi prices heart drug above expectations” (Reuters)
“Companies start shipping U.S. seasonal flu vaccine” (Reuters)

Posted in Industry Stories

Leave a Reply

You must be logged in to post a comment.